Doctors scrambling to get COVID-19 drug approved

A week after the FDA authorized the emergency use of Remdesivir, doctors are slamming the federal rollout of a critical drug that seems hard to get.
2:03 | 05/09/20

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for Doctors scrambling to get COVID-19 drug approved
On the front lines tonight across the country, many doctors asking, where the remdesivir, after the president and Dr. Fauci celebrated early data on the drug. How to get access for those who need it. Here's Matt Gutman. Reporter: David theile's father's been hospitalized for three weeks fighting covid. If it's a matter of life and death, that's -- that's what we're all about, making sure he has a fighting chance because that's what he wanted. Reporter: For nearly a week, his doctor scrambling to get him remdesivir, the first and only drug approved to treat covid. He's the sickest patient in our hospital right now. Reporter: Not only can you not secure the drug, you don't know how to get on a list to secure the drug. That is correct. Reporter: Tonight, one week after the fda authorized the emergency use of remdesivir, after a study suggested, the help patients recover faster, doctors across the country slamming the federal rollout of a critical drug that's not only scarce, but also not getting to the hospitals that need it most. It is very concerning and it really is in the midst of an epidemic, you wish we would have the drug available. Reporter: Tonight, the government said gilead promise doses but they're being shipped in batches. The government delivered 32,000 doses of remdesivir to hospitals in seven dates. But that's only enough for about 3,000 patients. Following the backlash over the role of the white house announcing Dr. Deborah birx will assist the HHS with distribution. She's the person who's constantly reviewing the numbers, constantly reviewing the data. Reporter: Just before we came on air we learned of a new study out of Hong Kong that's examining a triple anti-viral cocktail being administered to patients with slightly less severe symptoms and found the duration of the Sims was reduced from 12 days to 7 days. As you know, there is no cure, so speedy recovery Tim is key. Therapeutics and drugs before that vaccine. Matt, thank you.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"2:03","description":"A week after the FDA authorized the emergency use of Remdesivir, doctors are slamming the federal rollout of a critical drug that seems hard to get.","mediaType":"default","section":"ABCNews/WNT","id":"70588381","title":"Doctors scrambling to get COVID-19 drug approved","url":"/WNT/video/doctors-scrambling-covid-19-drug-approved-70588381"}